TGF-β autocrine loop regulates cell growth and myogenic differentiation in human rhabdomyosarcoma cells

FASEB Journal

Volumn 14, Issue 9, 2000, Pages 1147-1158

  Bouché, Marina ^a   Canipari, Rita ^a   Melchionna, Roberta ^a   Willems, Daniela ^a   Senni, Maria I ^a   Molinaro, Mario ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

Muscle regulatory factors; RD cells; Serine protease system; TPA

Indexed keywords

TRANSFORMING GROWTH FACTOR BETA;

ARTICLE; CANCER CELL CULTURE; CELL DIFFERENTIATION; CELL GROWTH; CELL TRANSFORMATION; GROWTH REGULATION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; RHABDOMYOSARCOMA;

EID: 0034046558     PISSN: 08926638     EISSN: None     Source Type: Journal    
DOI: 10.1096/fasebj.14.9.1147     Document Type: Article

References (41)

1. Malone, M. (1993) Soft tissue tumours in childhood [published erratum appears in Histopathology (1994) Vol. 24, p. 197]. Histopathology 23, 203-216
2. Bouche, M., Senni, M. I., Grossi, A. M., Zappelli, F., Polimeni, M., Arnold, H. H., Gossu, G., and Molinaro, M. (1993) TPA-induced differentiation of human rhabdomyosarcoma cells: expression of the myogenic regulatory factors. Exp. Cell Res. 208, 209-217
3. Tapscott, S. J., Thaver, M. J., and Weintraub, H. (1993) Deficiency in rhabdomyosarcomas of a factor required for MyoD activity and myogenesis. Science 259, 1450-1453
4. Davis, R. L., Weintraub, H., and Lassar, A. B. (1987) Expression of a single transfected cDNA converts fibroblast to myoblast. Cell 51, 987-1000
5. Wright, W. E., Sassoon, D. A., and Lin, V. K. (1989) Myogenin, a factor regulating myogenesis, has a domain homologous to MyoD. Cell 56, 607-617
6. Aguanno, S., Bouche, M., Adamo, S., and Molinaro, M. (1990) 12-O-tetradecanoylphorbol-13-acetate-induced differentiation of a human rhabdomyosarcoma cell line. Cancer Res. 50, 3377-3382
7. Bouche, M., Zappelli, F., Polimeni, M., Adamo, S., Wetsel, W. C., Senni, M. I., and Molinaro, M. (1995) Rapid activation and down-regulation of protein kinase C α in 12-O-tetradecanoyl-phorbol-13-acetate-induced differentiation of human rhabdomyosarcoma cells. Cell Growth & Differ. 6, 845-852
8. Brennan, T. J., Edmondson, D. G., Li, L., and Olson, E. N. (1991) Transforming growth factor beta represses the actions of myogenin through a mechanism independent of DNA binding. Proc. Natl. Acad. Sci. USA 88, 3822-3826
9. Martin, J. F., Li, L., and Olson, E. N. (1992) Repression of myogenin function by TGF-beta 1 is targeted at the basic helix-loop-helix motif and is independent of E2A products. J. Biol. Chem. 267, 10956-10960
10. Olson, E. N. (1992) Interplay between proliferation and differentiation within the myogenic lineage. Dev. Biol. 154, 261-272
11. Li. L., Zhou, J., James, G., Heller-Harrison, R., Czech, M. P., and Olson, E. N. (1992) FGF inactivates myogenic helix-loop-helix proteins through phosphorylation of a conserved protein kinase C site in their DNA-binding domains. Cell 71, 1181-1194
12. Derynck, R., Goeddel, D. V., Ullrich, A., Gutterman, J. U., Williams, R. D., Bringman, T. S., and Berger, W. H. (1987) Synthesis of messenger RNAs for transforming growth factors alpha and beta and the epidermal growth factor receptor by human tumors. Cancer Res. 47, 707-712
13. Massagué, J. (1990) The transforming growth factor-beta family. Annu. Rev. Cell Biol. 6, 597-641
14. Taipale, J., Miyazono, K., Heldin, C. H., and Keski-Oja, J. (1994) Latent transforming growth factor-β1 associates to fibroblast extracellular matrix via latent TGF β1 binding protein. J. Cell Biol. 124, 171-181
15. Lyons, R. M., Gentry, L. E., Purchio, A. F., and Moses, H. L. (1990) Mechanism of activation of latent recombinant transforming growth factor (1 by plasmin. J. Cell Biol. 110, 1361-1367
16. Derynck, R., Zhang, Y., and Feng, X. H. (1998) Smads: transcriptional activators of TGF-beta responses. Cell 95, 737-740
17. Dano, K., Andreasen, P. A., Grondahl-Hansen, J., Kristensen, P., Nielsen, L. S., and Skriver, L. (1985) Plasminogen activators, tissue degradation, and cancer. Adv. Cancer Res. 44, 139-266
18. Andreasen, P. A., Georg, B., Lund, I., R., Riccio, A., and Stacey, S. N. (1990) Plasminogen activator inhibitors: hormonally regulated serpins. Mol. Cell. Endocrinol. 68, 1-19
19. Vassalli, J. D., Baccino, D., and Belin, D. (1985) A cellular binding site for the Mr 55,000 form of the human plasminogen activator, urokinase. J. Cell Biol. 100, 86-92
20. Ploug, M., Ronne, E., Behrendt, N., Jensen, A. L., Blasi, F., and Dano, K. (1991) Cellular receptor for urokinase plasminogen activator. Carboxyl-terminal processing and membrane anchoring by glycosyl-phosphatidylinositol. J. Biol. Chem. 266, 1926-1933
21. Blasi, F. (1993) Urokinase and urokinase receptor: a paracrine/autocrine system regulating cell migration and invasiveness. Bioassays 15, 105-111
22. Sappino, A. P., Huarte, J., Belin, D., and Vassalli, J. D. (1989) Plasminogen activators in tissue remodeling and invasion: mRNA localization in mouse ovaries and implanting embryos. J. Cell Biol. 109, 2471-2479
23. Mignatti, P., Mazzieri, R., and Rifkin, D. B. (1991) Expression of the urokinase receptor in vascular endothelial cells is stimulated by basic fibroblast growth factor. J. Cell Biol. 113, 1193-1201
24. Wells, J. M., and Strickland, S. (1994) Aprotinin, a Kunitz-type protease inhibitor, stimulates skeletal muscle differentiation. Development 120, 3639-3647
25. De Giovanni, C., Melani, C., Nanni, P., Landuzzii, L., Nicoletti, G., Frabetti, F., Griffoni, G., Colombo, M. P., and Lollini, P. I., (1995) Redundancy of autocrine loops in human rhabdomyosarcoma cells: induction of differentiation by suramin. Br. J. Cancer 72, 1224-1229
26. Shapiro, D. N., Jones, B. G., Shapiro, L. H., Dias, P., and Houghton, P. J. (1994) Antisense-mediated reduction in insulin-like growth lactor-1 receptor expression suppresses the malignant phenotype of a human alveolar rhabdomyosarcoma. J. Clin. Invest. 94, 1235-1242
27. De Giovanni, C., Landuzzi, L., Frabetti, F., Nicoletti, G., Griffoni, C., Rossi, I., Mazzotti, M., Scotto, L., Nanni, P., and Lollini, P. I., (1996) Antisense epidermal growth factor receptor transfection impairs the proliferative ability of human rhabdomyosarcoma cells. Cancer Res. 56, 3898-3901
28. Abe, M., Harpel, J. G., Metz, C. N., Nunes, I., Loskutoff, D. J., and Rifkin, D. B. (1994) An assay for transforming growth factor-beta using cells transfected with a plasminogen activator inhibitor-1 promoter-luciferase construct. Anal. Biochem. 216, 276-284
29. Laemmli, U. K. (1970) Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature (London) 227, 680-685
30. Bader, D., Masaki, T., and Fischman, D. A. (1982) Immuno-chemical analysis of myosin heavy chain during avian myogenesis in vivo and in vitro. J. Cell Biol. 95, 763-770
31. Chomczynski, P., and Sacchi, N. (1987) Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chlorofrom extraction. Anal. Biochem. 162, 156-159
32. Verde, P., Stoppelli, M. P., Galeffi, P., Di Nocera, P., and Blasi, F. (1984) Identification and primary sequence of an unspliced human urokinase poly(A) + RNA. Proc. Natl. Acad. Sci. USA 81, 4727-4731
33. Roberts, A. B., Flanders, K. C., Kondaiah, P., Thompson, N. L., Van Obberghen-Schilling, E., Wakefield, L., Rossi, P., de Crombrugghe, B., Heine, U., and Sporn, M. B. (1988) Transforming growth factor beta: biochemistry and roles in embryogenesis, tissue repair and remodeling, and carcinogenesis. Recent Prog. Horm. Res. 44, 157-197
34. Belin, D., Godeau, F., and Vassalli, J. D. (1984) Tumor promoter PMA stimulates the synthesis and secretion of mouse pro-urokinase in MSV-transformed 3T3 cells: this is mediated by an increase in urokinase mRNA content. EMBO J. 3, 1901-1906
35. Baker, J. B., Low, D. A., Simmer, R. L., and Cunningham, D. D. (1980) Protease-nexin: a cellular component that links thrombin and plasminogen activator and mediates their binding to cells. Cell 21, 37-45
36. Chen, R. H., and Derynck, R. (1994) Homomeric interactions between type II transforming growth factor-beta receptors. J. Biol. Chem. 269, 22868-22874
37. Mayer, M., Lund, L. R., Riccio, A., Skouv, J., Nielsen, L. S., Stacey, S. N., Dano, K., and Andreasen, P. A. (1988) Plasminogen activator inhibitor type-1 protein, mRNA and gene transcription are increased by phorbol esters in human rhabdomyosarcoma cells. J. Biol. Chem. 263, 15688-15693
38. Filvaroff, E. H., Ebner, R., and Derynck, R. (1994) Inhibition of myogenic differentiation in myoblasts expressing a truncated type II TGF-beta receptor. Development 120, 1085-1095
39. Munoz-Canoves, P., Miralles, F., Baiget, M., and Felez, J. (1997) Inhibition of urokinase-type plasminogen activator (uPA) abrogates myogenesis in vitro. Thromb. Haemost. 77, 526-534
40. Quax, P. H., Frisdal, E., Pedersen, N., Bonavaud, S., Thibert, P., Martelly, I., Verheijen, J. H., Blasi, F., and Barlovatz-Meimon, G. (1992) Modulation of activities and RNA level of the components of the plasminogen activation system during fusion of human myogenic satellite cells in vitro. Dev. Biol. 151, 166-175
41. Wells, J. M., and Strickland, S. (1997) Regulated localization confers multiple functions on the protease urokinase plasminogen activator. J. Cell. Physiol. 171, 217-225